Allan, J., Lipsky, A., Bhat, S., Sundaram, S., Wu, L., Matejka, J., Hobbie, B., Hamadi, N., Morris, S., Chen, Z., Bander, I. S., Ouseph, M., Ruan, J., Chadburn, A., Kittai, A., Furman, R. (2025). Phase II study of polatuzumab in combination with chemoimmunotherapy for richter transformation (PolaR-EPCH).. Blood. https://doi.org/10.1182/blood-2025-3681